1. Biochemical and pharmacological aspects of Parkinsonism;Carlsson, A.;A cta neurol Scand,1972
2. The "on-off" response to chronic L-dopa treatment of Parkinsonism;Sweet, R.D.; McDowell, F.H.;Adv Neurol,1974
3. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy;Marsden, C.D.; Parkes, J.D.;Lancet,1976
4. Der L-3, 4dioxyphenylalanin (= Dopa) effekt beim Parkinson-syndrome des Menschen;Birkmayer, W, Hornykiewicz 0;Arch Psychiatr Nervenkrank
5. Potentiation of the L-dopa effect in man by the use of catechol-O-methyl transferase inhibitors;Ericsson, A.D.;J Neurol Sci,1971